Literature DB >> 3944632

Serum and urine zinc response in head-injured patients.

C J McClain, D L Twyman, L G Ott, R P Rapp, P A Tibbs, J A Norton, E J Kasarskis, R J Dempsey, B Young.   

Abstract

A prospective longitudinal evaluation of serum zinc concentrations was performed in 26 head-trauma patients, and 24-hour urine zinc excretion was determined in 15 of these subjects. Patients had markedly depressed admission serum zinc concentrations (mean +/- standard error of the mean: 40.2 +/- 3.2 micrograms/dl; normal values: 70 to 120 micrograms/dl), which gradually increased during the 16-day study period. All subjects demonstrated increased urinary zinc losses throughout the study period. Urinary zinc excretion was greater in patients with more severe head injuries. Indeed, patients with more severe head trauma had mean peak urinary zinc losses of greater than 7000 micrograms/day (normal less than 500 (micrograms/day). The implications of this altered zinc metabolism for protein metabolism, wound healing, and immune function, and the specific role of zinc in brain function and recovery from injury are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3944632     DOI: 10.3171/jns.1986.64.2.0224

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  17 in total

Review 1.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

Review 2.  Zinc in the central nervous system: From molecules to behavior.

Authors:  Shannon D Gower-Winter; Cathy W Levenson
Journal:  Biofactors       Date:  2012-03-31       Impact factor: 6.113

Review 3.  Supplements, nutrition, and alternative therapies for the treatment of traumatic brain injury.

Authors:  Brandon P Lucke-Wold; Aric F Logsdon; Linda Nguyen; Ahmed Eltanahay; Ryan C Turner; Patrick Bonasso; Chelsea Knotts; Adam Moeck; Joseph C Maroon; Julian E Bailes; Charles L Rosen
Journal:  Nutr Neurosci       Date:  2016-10-05       Impact factor: 4.994

4.  Impaired utilization of exogenous amino acids after surgery for subarachnoid haemorrhage.

Authors:  K Hersio; M Vapalahti; A Kari; J Takala; J Hernesniemi; A Tapaninaho; M Luukkonen
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

5.  Zinc supplementation provides behavioral resiliency in a rat model of traumatic brain injury.

Authors:  Elise C Cope; Deborah R Morris; Angus G Scrimgeour; Jacob W VanLandingham; Cathy W Levenson
Journal:  Physiol Behav       Date:  2011-06-16

6.  The relationship between transient zinc ion fluctuations and redox signaling in the pathways of secondary cellular injury: relevance to traumatic brain injury.

Authors:  Yuan Li; Bridget E Hawkins; Douglas S DeWitt; Donald S Prough; Wolfgang Maret
Journal:  Brain Res       Date:  2010-03-18       Impact factor: 3.252

Review 7.  Improving treatments and outcomes: an emerging role for zinc in traumatic brain injury.

Authors:  Elise C Cope; Deborah R Morris; Cathy W Levenson
Journal:  Nutr Rev       Date:  2012-05-22       Impact factor: 7.110

8.  Thyroid and thymic endocrine function and survival in severely traumatized patients with or without head injury.

Authors:  E Mocchegiani; R Imberti; D Testasecca; M Zandri; L Santarelli; N Fabris
Journal:  Intensive Care Med       Date:  1995-04       Impact factor: 17.440

9.  Increased circulating leukocyte numbers and altered macrophage phenotype correlate with the altered immune response to brain injury in metallothionein (MT)-I/II null mutant mice.

Authors:  Michael W Pankhurst; William Bennett; Matthew T K Kirkcaldie; Adrian K West; Roger S Chung
Journal:  J Neuroinflammation       Date:  2011-12-07       Impact factor: 8.322

10.  Metallothionein (MT) -I and MT-II expression are induced and cause zinc sequestration in the liver after brain injury.

Authors:  Michael W Pankhurst; David A Gell; Chris W Butler; Matthew T K Kirkcaldie; Adrian K West; Roger S Chung
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.